Trisomy 21 in Adulthood
Trisomy 21 in Adulthood. Evaluation of Health and Social State in Alsace (North-eastern France)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: ALEMBIK Yves, MD
- Phone Number: 33.3.88.12.50.89
- Email: yves.alembik@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Hopitaux Universitaires de Strasbourg
-
Contact:
- ALEMBIK Yves, MD
- Phone Number: 33.3.88.12.50.89
- Email: yves.alembik@chru-strasbourg.fr
-
Principal Investigator:
- ALEMBIK Yves, MD
-
Sub-Investigator:
- SCHAEFER Elise, MD
-
Sub-Investigator:
- EL CHEHADEH Salima, MD
-
Sub-Investigator:
- DOLLFUS Hélène, MD
-
Sub-Investigator:
- TIMBOLSCHI Dana Luiza, MD
-
Sub-Investigator:
- CHRISTMANN Dominique, MD
-
Sub-Investigator:
- MANIERE Marie-Cécile, MD
-
Sub-Investigator:
- DAVIDEAU Jean-Luc, MD
-
Sub-Investigator:
- KOENIG Anne, MD
-
Sub-Investigator:
- ROUL Gérard José, MD
-
Sub-Investigator:
- PETIT-EISENMANN Hélène, MD
-
Sub-Investigator:
- BLOCH-ZUPAN Agnès, MD
-
Sub-Investigator:
- BERNA Fabrice, MD
-
Sub-Investigator:
- PRADIGNAC Alain, MD
-
Sub-Investigator:
- GUFFROY Aurélien, MD
-
Sub-Investigator:
- KREMER Stéphane, MD
-
Sub-Investigator:
- PERDOMO-TRUJILLO Yaumara, MD
-
Sub-Investigator:
- KORGANOW Anne-Sophie, MD
-
Sub-Investigator:
- BLANC Frédéric, MD
-
Sub-Investigator:
- GAZZANO Elise, MD
-
Sub-Investigator:
- BRUN Isabelle, MD
-
Sub-Investigator:
- HIEBEL Jean-Michel, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Man or woman older than 18 years
- Down syndrome (clinical diagnosis, eventually confirmed by blood karyotype)
Exclusion Criteria:
- children
- pregnancy
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Trisomy 21 (Down syndrome)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: ALEMBIK Yves, MD, Hopitaux Universitaires de Strasbourg
Publications and helpful links
General Publications
- Dieudonne Y, Uring-Lambert B, Jeljeli MM, Gies V, Alembik Y, Korganow AS, Guffroy A. Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue. Front Immunol. 2020 May 8;11:840. doi: 10.3389/fimmu.2020.00840. eCollection 2020.
- Guffroy A, Dieudonne Y, Uring-Lambert B, Goetz J, Alembik Y, Korganow AS. Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center. Orphanet J Rare Dis. 2019 Jan 11;14(1):15. doi: 10.1186/s13023-018-0989-x.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 5249
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.